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Hereditary late-onset chorea 
without significant dementia:
Genetic evidence for substantial phenotypic 
variation in Huntington’s disease
J.W . B ritton , MD; R.J. U itti, MD; J.E . Ahlskog, MD, PhD; R.G. Robinson, MD; B. Kremer, MD, PhD;
and M.R. Hayden, MD, PhD, FRCPC
A rticle a b s tra c t—We examined five individuals and obtained information concerning six other members from two 
unrelated families, nearly all of whom developed chorea after age 50 (one patient developed chorea at age 40). The 
severity of chorea progressed in all patients and became disabling in some individuals approximately 15 years after 
onset. Cognitive impairment was absent or minimal, All five examined patients were cognitively normal, even 10 to 30 
years following the onset of chorea. Formal neuropsychometric testing demonstrated mild cognitive impairment in two 
individuals. Nevertheless, all patients were able to maintain employment or carry on with their usual household tasks 
until chorea was severe. One individual first became demented 30 years after the onset of chorea. Neuroimaging (with 
CT or MRI) in four patients failed to demonstrate significant caudate or putaminal atrophy 8 to 15 years following the 
onset of chorea, Three other family members (who were not available for examination) were said to have suffered 
chorea (without any mental decline) beginning after age 50, with subsequent survival of 20 years (in one) and 30 years 
(in two). Given this constellation of history and findings, three experienced neurologists and two medical geneticists 
concluded that these patients had a familial chorea syndrome distinct from Huntington’s disease (HD). However, ge­
netic analysis of the trinucleotide (CAG) repeat length associated with HD (in 4pl6.3) determined repeat lengths of 44 
and 4fi in four patients tested (within the HD range). We conclude that these patients have HD and that such families 
represent further convincing examples of significant phenotypic variation for HD.
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T he m o st com m only recognized  form of fam ilia l 
chorea is H un ting ton1» disease (HD). This condition 
is inexorably progressive and  is associated with de­
m entia, psychiatric  abnorm alities, and other neuro­
logic s igns in add ition  to chorea. Age of onset is 
usually  betw een 30 and 50 y e a rs ,1,2 Typically, dete­
rioration  resu lts  in dea th  a t  an average age of 54 
years, 15 to 20 years a fte r  disease onse ts  Clinical 
va rian ts  include a juvenile  form, w ith rigidity as a 
p rom inen t fea tu re ,•• and  late-onset HD.™
There, a re ,  h o w e v e r , o th e r  fo rm s of fa m ilia l  
chorea. For example, benign familial chorea, char­
ac te rized  by childhood o nse t and  a re la tively  b e ­
nign co u rse ,7 s ta n d s  in c o n tra s t  to HD, w hereas  
d e n ta to -ru b ro -p a ll id a l- lu y s ia n  a tro p h y  (DRPLA), 
ano ther autosom al dom inan t condition, m ay closely 
mimic HD.S O ther familial disorders w ith chorea as 
a p rom inen t feature  have also been described.9,10
T here  are  instances of late-onset, nonhered itary  
ch o rea  w ith o u t  o th e r  neu ro log ic  m a n ife s ta t io n s
d e s ig n a te d  as sen ile  chorea. Some have  a rg u e d  
th a t  senile  chorea m ay frequently  rep re sen t la te -  
onset H D .11 However, HD does not account for all 
reported  cases of senile chorea ,12 and there  is g e ­
netic evidence for senile chorea being a  distinct e n ­
tity  from H D .1;U1
We recently encountered two unre la ted  fam ilies 
w ith  11 m em bers affected by adu lt-onse t chorea. 
Each pedigree displayed a p a tte rn  compatible w ith  
an  autosom al dom inant mode of inheritance. Cog­
n itiv e  an d  p sy ch ia tr ic  dysfunction  w ere  a b se n t ,  
mild, or only p resen t m any years after the onset of 
chorea. Coupled w ith a prolonged, i'elatively benign 
course and a lack of neuroim aging abnorm alities , 
these  fea tu res  led th ree  experienced neuro log ists  
and  two medical geneticists expert in  HD to con­
clude th a t  these patien ts had  a familial chorea syn ­
drome th a t  was distinct from HD.
The recent discovery of the HD gene and its a s ­
sociated trinucleotide (CAG) repea t expansion h a s
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Figure 1. Pedigree of family 1, Symbols for persons 
examined and found affected with chorea are blackened. 
Symbols for persons with chorea by history alone (not 
examined by the authors) are crosshatched, IL8 and  
ILIO, not affected with chorea, developed dementia late 
in life. Arrow indicates proband. Squares = males; circles 
= females; slash marks = deceased.
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Figure 2, Pedigree of family 2. Symbols for persons 
examined and found affected with chorea are blackened. 
Arrow indicates proband. Squares -  males; circles = 
females; slash marks = deceased.
facilitated confirmation of diagnosis in symp­
tomatic patients.15 We applied polymerase chain re­
action (PCR) analysis of the HD trinucleotide re­
peat sequence16'18 to affected members of these two 
families with late-onset chorea to determine 
whether they indeed represented a unique disorder 
of familial late-onset chorea or HD with an atypical 
presentation.
Methods. Clinical information. Pedigrees of two unre­
lated families with late-onset chorea are illustrated in 
ñgures 1 and 2. Case reports concerning affected mem­
bers are presented below.
PCR analyses. Trinucleotide repeat length analyses 
were performed on two members from each family (III. 8 
and III. 10 from family 1 and III. 12 and 111.14 from fam­
ily 2). Nuclear DNA was isolated by extraction from 
leukocytes using the method of Kunkel et al.19 The CAG 
repeat size was measured as previously described.17 As­
sessment of the trinucleotide repeat length included 76 
base pairs on non-CAG sequences, which were then sub­
tracted from the observed size. The resulting value was 
divided by three to obtain the CAG repeat length.
Case reports . Family 1 (figure 1). III.8. The proband 
had a 15-year history of mild, generalized, slowly pro­
gressive chorea when first seen at age 65 years. She was 
a homemaker and continued to perform all her normal 
household duties without difficulty 15 years after onset 
of chorea. Apart from chorea, she had no other com­
plaints. On direct questioning, she thought tha t she 
might have had a mild decline in memory, but her hus­
band disagreed with this impression. Medical history 
was significant only for a 15-year history of hypertension 
and mild hypercholesterolemia.
Neurologic findings were limited to mild generalized 
chorea and hyperkinetic dysarthria. Her Mini-Mental 
State Examination20 score was 38 of 38 (within the nor­
mal range).
She scored in the average range on the following neu­
ropsychological tests: Wechsler Adult Intelligence Scale- 
Revised (WAIS-R) (Full Scale IQ = 94), Wechsler Mem­
ory Scale-Revised (WMS-R), Auditory-Verb al Learning 
Test (AVLT), Wide-Range Achievement Test-Revised, 
Stroop’s Color Word Test, Trail Making Test, Bender- 
Gestalt, Boston Naming Test, and Russell’s Category 
Test. Mildly subnormal scores were recorded on two 
tests—the Wisconsin Card Sorting Test and the Con­
trolled Oral Word Association Test, These results were 
considered consistent with her education and occupa­
tional background.
An MRI of the brain performed 15 years after the 
onset of chorea showed mild generalized atrophy (figure 
3a). A blood smear for acanthocytes, slit-1 amp examina­
tion, urine screen for inborn errors of metabolism, gen­
eral chemistry panel, ceruloplasmin level, antinuclear 
antibody (ANA) level, thyroid-stim ulating hormone 
(TSH) level, vitamin B12 and folic acid levels, and hema­
tology group were all normal or negative.
III.10. The brother of the proband was initially seen 
at age 63, after a 10-year history of mild generalized 
chorea. He had no complaints apart from chorea. He con­
tinued to operate a successful farm independently, per­
forming all his usual chores. He was not aware of any 
change in his cognitive capacity. On direct questioning, 
his wife thought that he may have had a subtle decline 
in memory and had become somewhat indecisive since 
age 61 years. He had no history of psychiatric illness.
Neurologic examination showed mild generalized 
chorea and mildly impaired rapid alternating movements 
bilaterally. The Mini-Mental State Examination revealed 
impaired delayed verbal recall (he recalled one of four 
words learned after a 5-minute delay) but was otherwise 
normal (total score: 35/38).
Neuropsychological testing revealed limited abnor­
malities. These were restricted to impaired verbal learn­
ing and retention on the AVLT (he learned eight of 15 
words after five trials and recalled three after 30 min­
utes). The WAIS-R was performed in the average range 
(Pull Scale IQ = 97), consistent with his education and 
occupational background. A brain MRI 10 years after the 
onset of chorea showed mild generalized cerebral atrophy 
(figure 3b). A blood smear for acanthocytes, slit-lamp ex­
amination, chemistry panel, vitamin B12 and folic acid, 
FTA-ABS, and TSH were normal or negative. An ANA 
titer was 1:160.
II.4. The mother of the proband had been evaluated by 
neurologists at the University of Iowa in 1953 and at the 
Mayo Clinic in 1958. Neither senior neurologist sus-
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at a ge 85, 33 years after the onset of chorea. She weighed 
60 pounds at the time of death.
Her mother, father, and two sisters all died in the sev­
enth and eighth decades of life. None had any neurologic 
or psychiatric disorder. Her two other siblings died im­
mediately after birth and at age 16 from diphtheria. One 
paternal uncle was said to have had “St. Vitus’ dance” at 
one time and died in his thirties (of unknown cause). No 
other relatives were known to have had any neurologic 
diseases.
DNA analyses. The upper allele CAG trinucleotide re­
peat length was 46 units in both patients IIL8 and III. 10 
from family 1 and 44 units in both patients III. 12 and 
III. 14 from family 2. An upper allele repeat sequence of 
>36 triplets is considered to be within the HD range.14
Discussion. The two families described here share 
certain features that are atypical of HD; (1) demen­
tia was not a prominent feature; (2) survival follow­
ing onset of chorea was prolonged, with deceased 
patients dying an average of 28 years after chorea 
began; and (3) neuroimaging, performed between 8 
and 15 years after the onset of chorea in four indi­
viduals, showed no disproportionate caudate or 
putaminal atrophy.
Dementia was absent or minimal in four of the 
five examined patients, as it was for all four de­
ceased patients from family 1 who died after a 20- 
to 30-year history of chorea. In contrast, significant 
cognitive and psychiatric decline is a hallmark of 
HD, usually leading to disability within a few years 
after diagnosis.21 Patient III. 14 from family 2 did 
show a decline on serial neuropsychological test 
scores; however, his chorea and dysarthria signifi­
cantly interfered with psychological testing, con­
founding the results. Despite his scores, he was 
still able to provide a logical history 17 years after 
symptom onset. Likewise, III. 10 from family 1 
demonstrated abnormalities on memory testing but 
continued to function as a capable farmer. Patients 
with late-onset HD often exhibit a milder degree of 
dementia than those with earlier onset; however, 
the largest series of late-onset HD patients noted 
that all 25 examined patients were definitely de­
mented within 7 years of the onset of chorea.5 The 
individuals in our series did not demonstrate de­
mentia, not even of a mild degree, until between 8 
and 30 years after chorea onset.
The patients in these two families remained free 
from disability for at least 10 years following the 
onset of chorea. Survival of affected members in 
our two families was longer than the 15 to 20 years 
typically seen in HD (28 years on average in the 
five deceased patients).3 The 33-year survival after 
onset of chorea seen in patient 11.10 (family 2) is 
one of the longest ever reported in an HD patient. 
In one large series,1 no patient survived more than 
27 years. However, MacMillan et al22 recently re­
ported several individuals originally thought to 
have benign hereditary chorea who had HD proven 
by identification of trinucleotide expansion.
Consistent absence of disproportionate caudate 
and putaminal atrophy is also atypical for HD. In­
dividual patients with advanced HD and normal 
neuroimaging are unusual.21 In a prior series of pa­
tients with late-onset HD,5 all nine patients who 
underwent CT had caudate atrophy. Others have 
shown that loss of putamen volume may be a more 
sensitive finding than caudate atrophy in “mild 
HD” (in which cognitive processing is minimally af­
fected).23
Despite their atypical clinical features, the DNA 
analysis in these patients indicates that they have 
inherited the mutation associated with HD. Their 
CAG trinucleotide repeat lengths fall within the 
range identified in late-onset HD.24 In a study of 
133 patients with late-onset HD from 107 separate 
families, there was a significant negative correla­
tion between the length of repeat and age of onset 
for the total cohort. However, for persons with 
onset age greater than 60, there was no significant 
correlation.24 With increasing age of onset, the ef­
fect of the repeat length on onset age appears to di­
minish.
The reason for the atypical phenotypic expres­
sion in our patients is unclear. Some of the pheno­
typic variability in HD can be attributed to the 
CAG repeat sequence length. For example, repeat 
length is inversely correlated with age of 
onset.15,25-27 Repeat length can also be correlated 
with disease severity. Patients with juvenile-onset 
HD tend to have a more severe and rapidly pro­
gressive course4 and generally exhibit long repeat 
sequence lengths.15,25'27 However, there are notable 
examples of marginally prolonged repeat lengths 
occurring in childhood-onset HD.22 Repeat length 
alone explains about 50% of the total variance in 
onset age.25 Furthermore, in a large genetic analy­
sis series restricted to late-onset HD, repeat length 
accounted for only 7% of the variation in age of 
onset for persons beyond the age of 50 years.24 
Likewise, there was no significant correlation be­
tween age of onset and size of the lower allele re­
peat length or the sex of the affected parent or 
grandparent in this series.24 Finally, a small num­
ber of patients clinically diagnosed as having HD 
have not shown an expanded CAG repeat with a 
novel gene on 4pl6.3. In at least four such cases, 
studies have excluded 4pl6.3 as the region respon­
sible for the HD phenotype.28
That all cases in our two families aggregated as 
late-onset HD suggests that other genetic factors 
may be involved. When it is determined how the 
CAG repeat expansion relates to HD, it may be­
come apparent how certain clinical features are 
produced. Accumulating evidence suggests that the 
protein product of IT15 may be a DNA-binding pro­
tein involved in transcriptional regulation.29 If an 
expanded polyglutamine (glutamine being the 
amino acid encoded by CAG) stretch leads to al­
tered expression of other genes, a wide range of 
phenotypic variation might be explained. In this re­
gard, aspects of another autosomal dominant condi­
tion, DRPLA, which may closely mimic HD clini­
cally, are of great interest. Until recently, in some
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instances DRPLA and HD could only be differenti­
ated by neuropathologic examination (in which 
major involvement of the globus pallidus, subtha­
lamic nucleus, and dentate nuclei distinguished 
DRPLA from HD).8 DRPLA is associated with an­
other CAG repeat expansion, this one occurring on 
chromosome 12,30 Such expansions may allow for 
the development of specific neurologic features in­
cluding chorea, dementia, and psychiatric distur­
bances. Further genetic evaluations of families 
with unusual HD phenotypes, such as the patients 
described, may contribute to an understanding of 
the biology of phenotypic expression in HD,
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